Provention Bio, Inc.

PRVBDelisted Apr 27, 2023

Industry: Pharmaceutical Preparations
SEC CIK: 0001695357

SEC filings (opens in a new tab)

Provention Bio, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on Apr 28, 2023; 183 institutions reported holding it in 13F filings for Q1 2023, worth $1.47B in total; Fairfax Financial was the only superinvestor holding it.

Q2 2022 vs. Q1 2022

How the institutions holding Provention Bio, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of PRVB: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	113	3	115	+5
Shares	24.2M	91.9K	25.0M	+902.3K (+3.7%)
Value	$177.0M	$673.0K	$99.9M	−$76.4M (−43.3%)

3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Provention Bio, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to PRVB in Q2 2022
Institution	Shares	Value	% of portfolio
MPM Oncology Impact Management LP	592,435	$2.37M	0.66%
Renaissance Technologies LLC	166,747	$667.0K	0.00%
Group One Trading, L.P.	74,581	$298.0K	0.01%
Russell Investments Group, Ltd.	67,333	$269.0K	0.00%
Jump Financial, LLC	55,461	$222.0K	0.01%
HRT Financial LP	45,043	$180.0K	0.00%
Millennium Management LLC	42,540	$170.0K	0.00%
Prudential Financial Inc	33,500	$134.0K	0.00%
XTX Topco Ltd	33,553	$134.0K	0.05%
Delphia (USA) Inc.	25,698	$103.0K	0.07%
Corton Capital Inc.	23,548	$94.0K	0.09%
Virtu Financial LLC	17,775	$71.0K	0.01%
Mirae Asset Global Investments Co., Ltd.	17,299	$70.0K	0.00%
Marshall Wace, LLP	17,108	$69.0K	0.00%
Principal Financial Group Inc	14,998	$60.0K	0.00%
Parallax Volatility Advisers, L.P.	14,800	$59.0K	0.00%
State of Wisconsin Investment Board	12,994	$52.0K	0.00%
Prelude Capital Management, LLC	12,064	$48.0K	0.00%
Aspiriant, LLC	11,000	$44.0K	0.00%
Dynamic Technology Lab Private Ltd	10,542	$42.0K	0.00%
Old Mission Capital LLC	10,283	$41.0K	0.00%
Point72 Hong Kong Ltd	5,184	$21.0K	0.00%
Ancora Advisors, LLC	1,000	$4.00K	0.00%
Steward Partners Investment Advisory, LLC	450	$2.00K	0.00%

Sold out (19)

Institutions that held Provention Bio, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of PRVB in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Nisa Investment Advisors, LLC	45,400	$332.0K
Atom Investors LP	42,680	$312.0K
HAP Trading, LLC	37,539	$275.0K
Graham Capital Management, L.P.	37,060	$271.0K
Virtus ETF Advisers LLC	26,467	$194.0K
Jane Street Group, LLC	19,661	$144.0K
Private Advisor Group, LLC	17,707	$129.0K
Franklin Resources Inc	16,926	$124.0K
Engineers Gate Manager LP	16,500	$121.0K
ExodusPoint Capital Management, LP	12,500	$92.0K
Sawtooth Solutions, LLC	10,221	$75.0K
BIT Capital GmbH	7,500	$54.9K
High Net Worth Advisory Group LLC	2,500	$18.0K
Captrust Financial Advisors	1,394	$10.0K
Money Concepts Capital Corp	571	$4.00K
Quadrant Capital Group LLC	147	$1.00K
Toronto Dominion Bank	6	$0
Signaturefd, LLC	65	$0
Financial Management Professionals, Inc.	64	$0

Not filed for Q2 2022 yet (3)

Institutions that held Provention Bio, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PRVB in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Parametric Portfolio Associates LLC	67,219	$492.0K
Susquehanna Fundamental Investments, LLC	17,993	$132.0K
Amalgamated Financial Corp.	6,706	$49.0K